Latest Pseudomonas aeruginosa Stories
Study Expected to Complete in 4Q 2015 SAN JOSE, Calif., March 26, 2015 /PRNewswire/ -- Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to
Patent awarded on Feb.
RnRMarketResearch.com adds "Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014" to its store.
Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.
- Potential Treatment for Hospitalized Patients with Complicated Intra-Abdominal and Complicated Urinary Tract Infections - DUBLIN, Dec.
KB004 Phase 1/2 Clinical Data in Hematologic Malignancies to be presented at the 56th American Society of Hematology Annual Meeting and Exposition SOUTH SAN FRANCISCO, Calif., Nov.
The Oliver Law Group P.C.
Innovative Treatment to Improve Lung Function and Antibiotic Effectiveness in CF Patients Claremont, CA (PRWEB) October 02, 2014 Cystic fibrosis (CF)
ALBANY, New York, September 8, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pipeline Analysis of Hospital Acquired Pneumonia
Pseudomonas aeruginosa is a common bacterium that can cause disease in animals and humans. It can be found in soil, water, skin flora, and most man-made environments throughout the world. It thrives in normal or hypoxic atmospheres; due to this it has colonized many natural and artificial environments. It can infect animals with damaged tissue or people with reduced immunity. Symptoms are generalized inflammation and sepsis. It can be fatal if colonization occurs in critical body organs,...
- The governor of a province or people.